Template:Clonidine: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 41: | Line 41: | ||
|- | |- | ||
|} | |} | ||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Clonidine|{{fontcolor|#6C7B8B|Clonidine}}]]''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CLONIDINE patch <sup>®</sup> FDA Package Insert | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine indications and usage|Indications and Usage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine dosage and administration|Dosage and Administration]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine dosage forms and strengths|Dosage Forms and Strengths]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine contraindications|Contraindications]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine warnings and precautions|Warnings and Precautions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine adverse reactions|Adverse Reactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine drug interactions|Drug Interactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine use in specific populations|Use in Specific Populations]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine overdosage|Overdosage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine description|Description]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine clinical pharmacology|Clinical Pharmacology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine nonclinical toxicology|Nonclinical Toxicology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine clinical studies|Clinical Studies]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine how supplied storage and handling|How Supplied/Storage and Handling]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine patient counseling information|Patient Counseling Information]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine labels and packages|Labels and Packages]] | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Clonidine | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | |||
|- | |||
|} | |||
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Clonidine|{{fontcolor|#6C7B8B|Clonidine}}]]''''' | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | DURACLON (clonidine hydrochloride) injection<sup>®</sup> FDA Package Insert | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine indications and usage|Indications and Usage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine dosage and administration|Dosage and Administration]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine dosage forms and strengths|Dosage Forms and Strengths]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine contraindications|Contraindications]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine warnings and precautions|Warnings and Precautions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine adverse reactions|Adverse Reactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine drug interactions|Drug Interactions]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine use in specific populations|Use in Specific Populations]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine overdosage|Overdosage]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine description|Description]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine clinical pharmacology|Clinical Pharmacology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine nonclinical toxicology|Nonclinical Toxicology]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine clinical studies|Clinical Studies]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine how supplied storage and handling|How Supplied/Storage and Handling]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine patient counseling information|Patient Counseling Information]] | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Clonidine labels and packages|Labels and Packages]] | |||
|- | |||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Clonidine | |||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov] | |||
|- | |||
|} | |||
<br> | |||
Revision as of 15:53, 5 February 2014
| Clonidine |
|---|
| DURACLON (clonidine hydrochloride) injection® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Dosage Forms and Strengths |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| Clinical Studies |
| How Supplied/Storage and Handling |
| Patient Counseling Information |
| Labels and Packages |
| Clinical Trials on Clonidine |
| ClinicalTrials.gov |